Tobacco use disorder

Last updated: June 19, 2025

Tobacco use disorder

GMED

GMED

Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Asthma: Clinical
Asthma
Asthma: Information for patients and families (The Primary School)
Chronic kidney disease
Chronic kidney disease: Clinical
Anemia of chronic disease
Kidney stones
Acute kidney injury: Clinical
Anatomy of the abdominal viscera: Kidneys, ureters and suprarenal glands
Prerenal azotemia
Renal system anatomy and physiology
Renal azotemia
Postrenal azotemia
Renal failure: Pathology review
Taking a good patient history
Using an inhaler: Information for patients and families
Macrocytic anemia: Pathology review
Anemia: Clinical
Aplastic anemia
Extrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Autoimmune hemolytic anemia
Non-hemolytic normocytic anemia: Pathology review
Iron deficiency anemia
Intrinsic hemolytic normocytic anemia: Pathology review
Megaloblastic anemia
Obstructive lung diseases: Pathology review
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Cholinomimetics: Direct agonists
General anesthetics
Pulmonary corticosteroids and mast cell inhibitors
Isolated primary immunoglobulin M deficiency
Muscarinic antagonists
Cell-mediated immunity of CD4 cells
Adrenergic antagonists: Beta blockers
Non-steroidal anti-inflammatory drugs
Chronic obstructive pulmonary disease (COPD): Clinical
Clinical Skills: Using a metered-dose inhaler
Psychomotor stimulants
Tobacco use disorder
Cholinomimetics: Indirect agonists (anticholinesterases)
Sympathomimetics: Direct agonists
Jaundice
Neonatal jaundice: Clinical
Jaundice: Clinical
Jaundice: Pathology review
Cholestatic liver disease
Cirrhosis
Cirrhosis: Pathology review
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Cirrhosis: Clinical
Urinary tract infections: Clinical
Urinary incontinence
Urinary incontinence: Pathology review
Renal and urinary tract masses: Pathology review
Bladder exstrophy
Neurogenic bladder
Elimination disorders: Clinical
Cholinergic receptors
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Small bowel ischemia and infarction
Bowel obstruction: Clinical
Diarrhea: Clinical
Electrolyte disturbances: Pathology review
Laxatives and cathartics
Acetaminophen (Paracetamol)
Peptic ulcer
Peptic ulcers and stomach cancer: Clinical
Gastrointestinal bleeding: Pathology review
Ulcerative colitis
Liver histology
Alcohol-associated liver disease
Liver anatomy and physiology
Non-alcoholic fatty liver disease
Anatomy of the abdominal viscera: Liver, biliary ducts and gallbladder
Hepatic encephalopathy
Gastrointestinal system anatomy and physiology
Bowel obstruction
Enteric nervous system
Pulmonary hypertension
Pulmonary edema
Osteoarthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Joint pain: Clinical
Gout
Gout and pseudogout: Pathology review
Antigout medications
Glucocorticoids
Osmotic diuretics
Loop diuretics
Potassium sparing diuretics
Thiazide and thiazide-like diuretics
Diabetic nephropathy
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory alkalosis: Clinical
Hyponatremia
Metabolic alkalosis
Hypernatremia: Clinical
Hypertension: Clinical
Hyperphosphatemia
Hypokalemia
Hyponatremia: Clinical
Hypernatremia
Hypermagnesemia
Hyperkalemia
Hypercalcemia
Portal hypertension
Rheumatoid arthritis: Clinical
Rheumatoid arthritis
Hypocalcemia
Hypoxia
Hypomagnesemia
Hypophosphatemia
Orthostatic hypotension

Transcript

Watch video only

There are over a billion people who smoke tobacco around the world, which makes it one of the most popular psychoactive substances used in society.

The majority of tobacco users smoke cigarettes, but some smoke cigars or pipes, chew tobacco, or practice snuffing, which is where ground-up tobacco leaves are pushed up the nose.

Given the popularity of tobacco as well as its negative health consequences, it’s considered one of the leading causes of preventable death and disease worldwide.

Cigarette smoke contains over 4,000 toxic chemicals.

These toxins cause endothelial cell damage which creates inflammation along the inner lining of arteries.

The inflammation increases the risk of having a myocardial infarction (or heart attack), a stroke, and peripheral vascular disease which causes severe pain in the lower legs.

The toxins in cigarette smoke can also cause pulmonary problems when they’re deposited into the lungs, as they damage the lung tissue and increase the likelihood of developing a lung infection.

Finally, cigarette smoke contains many different carcinogens including ammonia, formaldehyde, and carbon monoxide, all of which are associated with cancers of the mouth, throat, lung, bladder, pancreas, and uterus.

Combining these effects, a heavy smoker who smokes two packs of cigarettes each day for 20 years loses about 14 years of life.

Despite the negative consequences of smoking, most people continue to smoke because tobacco contains nicotine, a tiny, fat-soluble molecule that creates pleasurable psychoactive effects and is extremely addictive.

Nicotine is considered “responsible” for the high rates of tobacco dependence and addiction, while the 4,000 other chemicals and compounds are “responsible” for the negative health effects associated with smoking.

When a cigarette is lit, some of the nicotine is destroyed by the heat, and some gets into the smoke that’s then inhaled.

As a result, smokers are able to “self-titrate” their nicotine dose by inhaling more frequently, more deeply, or for a longer amount of time.

Once nicotine is absorbed into the bloodstream, it binds to a type of acetylcholine receptor, called a nicotinic acetylcholine receptor—also called a nicotinic receptor—which is found throughout the body and brain.

In the central nervous system, nicotinic receptors are on pre-synaptic axon terminals of neurons, and when nicotine binds to them, it triggers the release of neurotransmitters like dopamine, acetylcholine, and glutamate, which is why it’s considered an acetylcholine agonist.

The psychoactive effects of nicotine are related to the locations of nicotinic receptors in the brain and the exact neurotransmitters that are released when those receptors are stimulated.

For example, increased dopamine in the mesolimbic system (a reward pathway composed of the ventral tegmentum and the nucleus accumbens) causes pleasure, improved attention span and mental processing, as well as increases in working memory.

Nicotine directly increases dopamine levels in the nucleus accumbens, but it also increases glutamate levels, causing the ventral tegmentum neurons to release more dopamine into the nucleus accumbens.

Nicotine also decreases the activity of inhibitory GABA neurons in the ventral tegmentum, so by inhibiting the inhibitory neurons there’s a double negative, meaning this is one more way to produce an increase in dopamine levels.

When nicotine binds to receptors in the peripheral nervous system, it increases blood pressure, heart rate, cardiac contractility, and gastrointestinal tract activity.

Nicotine also binds to receptors on skeletal muscles causing relaxed muscle tone.

Over time, individuals who consistently use cigarettes can develop tolerance to the effects of nicotine.

This means that with repeated use, they have a reduced response to nicotine, and therefore an increased dose of nicotine is needed to achieve the original response.

On a cellular level, there are a couple theories that explain why this might happen.

One is that repeated exposure to nicotine may cause nicotinic receptors to become less sensitive to nicotine.

Another theory is that neurons may remove nicotinic receptors from the cell wall in a process called down-regulation, leaving fewer receptors available for binding.

In either scenario, tolerance leads to the need for higher and higher doses of nicotine over time.

Let’s step back for a moment and say that you’re at rest, without anything stimulating your reward pathway.

In this situation, your brain keeps your heart rate, blood pressure and wakefulness in a normal state called homeostasis.

Now, let’s say that your secret crush sends you a text. All of a sudden you may feel sweaty and flushed, your heart rate may jump a bit.

Key Takeaways

Tobacco dependence, also known as nicotine dependence, is a chronic addiction to nicotine, a substance found in tobacco products such as cigarettes, cigars, and chewing tobacco. Nicotine stimulates the release of dopamine in the brain, which creates a pleasurable sensation and reinforces the behavior of smoking, leading to dependence.

Symptoms of tobacco dependence may include strong cravings for nicotine, difficulty quitting, withdrawal symptoms such as irritability, anxiety, and difficulty concentrating, and a continued use of tobacco despite negative consequences on health, social life, or finances.

Tobacco dependence is a serious health concern and increases the risk for heart attacks, strokes, chronic obstructive pulmonary disease (COPD), emphysema, and cancer (particularly lung cancer, cancers of the larynx and mouth, esophageal cancer and pancreatic cancer). Treatment for tobacco dependence includes nicotine replacement therapy, medications such as bupropion or varenicline, and counseling or support groups.